Careers Denmark
Se alle job

Business Development

Scientific Director, Cardiovascular Disease

Novo Nordisk A/S Måløv, Capital Region of Denmark, DK Publiceret 1. okt. 2026 Novo Nordisk A/S public ATSChef / direktør940.800–1.448.700 DKK om året
Læst af AI
Læst fra jobopslaget af AI. Arbejdsgiverens egne felter vinder altid.

Resumé

Provides scientific and strategic leadership for cardiovascular disease, shaping early-pipeline priorities, portfolio decisions and external innovation assessments. Works across research, development and business development teams.

Læst af AI
Læst fra jobopslaget af AI. Arbejdsgiverens egne felter vinder altid.

Kort om jobbet

Pay: 940,800–1,448,700 DKK per year. Country: Denmark. Your impact begins here As Scientific Director, Cardiovascular Disease, you will help shape the scientific strategy and early pipeline across cardiovascular disease.

Working in a highly matrixed organisation, you will operate at the interface of Early Discovery, Translational Science and Medical, bringing together expertise across functions to inform portfolio priorities and project decisions. You will lead selected cross-functional initiatives and contribute to the evaluation of external innovation and business development opportunities.

By translating emerging science into clear recommendations and longer-term therapeutic area priorities, you will help advance potential new treatments for people living with cardiovascular and cardiometabolic diseases. What you’ll bring You bring deep scientific credibility, strategic judgement, strong business acumen and the ability to influence senior stakeholders across a complex global organisation.

We expect you to have:

- A PhD, MD or equivalent scientific background within cardiovascular or cardiometabolic biology, combined with substantial experience from drug discovery, early development, portfolio strategy or related R&D roles1 …

Dette er et forkortet uddrag af det offentlige jobopslag. Følg det originale opslag for at se den fulde og autoritative beskrivelse.